[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hydroxycarbamide Market Data Survey Report 2013-2025

May 2019 | 66 pages | ID: G435C9019FDEN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.
The global Hydroxycarbamide market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:

Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type

Key manufacturers are included based on company profile, sales data and product specifications etc.:
  • Taj Pharma
  • Bristol Myers Squibb
  • Beijing Jialin Pharma
  • Qilu Pharmaceutical
  • Teva Pharma
  • Cipla
  • Zydus Cadila
  • United Biotech
  • Par Pharma
  • Khandelwal Laboratories
  • Alkem (Cytomed)
  • Samarth Pharma
  • VHB Life Sciences
Major applications as follows:
  • Sickle Cell Disease
  • Cancer
  • Others
Major Type as follows:
  • Capsule
  • Tablet
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.4 Scope of Type
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Taj Pharma
  3.1.1 Company Information
  3.1.2 Product & Services
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.1.4 Recent Development
3.2 Bristol Myers Squibb
  3.2.1 Company Information
  3.2.2 Product & Services
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.2.4 Recent Development
3.3 Beijing Jialin Pharma
  3.3.1 Company Information
  3.3.2 Product & Services
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.3.4 Recent Development
3.4 Qilu Pharmaceutical
  3.4.1 Company Information
  3.4.2 Product & Services
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.4.4 Recent Development
3.5 Teva Pharma
  3.5.1 Company Information
  3.5.2 Product & Services
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.5.4 Recent Development
3.6 Cipla
  3.6.1 Company Information
  3.6.2 Product & Services
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.6.4 Recent Development
3.7 Zydus Cadila
  3.7.1 Company Information
  3.7.2 Product & Services
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.7.4 Recent Development
3.8 United Biotech
  3.8.1 Company Information
  3.8.2 Product & Services
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.8.4 Recent Development
3.9 Par Pharma
  3.9.1 Company Information
  3.9.2 Product & Services
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.9.4 Recent Development
3.10 Khandelwal Laboratories
  3.10.1 Company Information
  3.10.2 Product & Services
  3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.10.4 Recent Development
3.11 Alkem (Cytomed)
  3.11.1 Company Information
  3.11.2 Product & Services
  3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  3.11.4 Recent Development
3.12 Samarth Pharma
  3.12.1 Company Information
  3.12.2 Product & Services
  3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.13 VHB Life Sciences
  3.13.1 Company Information
  3.13.2 Product & Services
  3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 Sickle Cell Disease
  4.1.1 Overview
  4.1.2 Sickle Cell Disease Market Size and Forecast
4.2 Cancer
  4.2.1 Overview
  4.2.2 Cancer Market Size and Forecast
4.3 Others
  4.3.1 Overview
  4.3.2 Others Market Size and Forecast

5 MARKET BY TYPE BY CAPSULE

5.1 Capsule
  5.1.1 Overview
  5.1.2 Capsule Market Size and Forecast
5.2 Tablet
  5.2.1 Overview
  5.2.2 Tablet Market Size and Forecast

6 PRICE OVERVIEW

6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type

7 CONCLUSION

LIST OF TABLES

Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Taj Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bristol Myers Squibb
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Beijing Jialin Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Qilu Pharmaceutical
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Teva Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Cipla
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Zydus Cadila
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of United Biotech
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Par Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Khandelwal Laboratories
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Alkem (Cytomed)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Samarth Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of VHB Life Sciences

LIST OF FIGURES

Fig Global Hydroxycarbamide Market Size and CAGR 2013-2018 (Million USD)
Fig Global Hydroxycarbamide Market Size and CAGR 2013-2018 (Volume)
Fig Global Hydroxycarbamide Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Hydroxycarbamide Market Forecast and CAGR 2019-2025 (Volume)
Fig Sickle Cell Disease Market Size and CAGR 2013-2018 (Million USD)
Fig Sickle Cell Disease Market Size and CAGR 2013-2018 (Volume)
Fig Sickle Cell Disease Market Forecast and CAGR 2019-2025 (Million USD)
Fig Sickle Cell Disease Market Forecast and CAGR 2019-2025 (Volume)
Fig Cancer Market Size and CAGR 2013-2018 (Million USD)
Fig Cancer Market Size and CAGR 2013-2018 (Volume)
Fig Cancer Market Forecast and CAGR 2019-2025 (Million USD)
Fig Cancer Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)
Fig Capsule Market Size and CAGR 2013-2018 (Million USD)
Fig Capsule Market Size and CAGR 2013-2018 (Volume)
Fig Capsule Market Forecast and CAGR 2019-2025 (Million USD)
Fig Capsule Market Forecast and CAGR 2019-2025 (Volume)
Fig Tablet Market Size and CAGR 2013-2018 (Million USD)
Fig Tablet Market Size and CAGR 2013-2018 (Volume)
Fig Tablet Market Forecast and CAGR 2019-2025 (Million USD)
Fig Tablet Market Forecast and CAGR 2019-2025 (Volume)


More Publications